Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
Submitted by
admin
on June 2, 2014 - 9:40am
Source:
Yahoo/Fly on the Wall
News Tags:
AbbVie
ABT-199
GDC-0199
B-cell lymphoma
ASCO
Headline:
AbbVie releases interim results from Phase Ib trial of ABT-199/GDC-0199
Do Not Allow Advertisers to Use My Personal information
